Literature DB >> 16341515

[Adverse drugs reactions: diagnosis and assessment].

P A Thürmann1.   

Abstract

Adverse drug reactions (ADR) occur in about 5% of all pharmacologically treated patients. Between 2% and 20% of all hospital admissions are caused by ADR, and approximately 10% of all hospitalized patients experience ADR during their hospital stay. Several thousand patients die due to ADR in Germany each year. ADR-associated drugs come predominantly from the class of non-steroidal antiinflammatory drugs, anticoagulants, acetylsalicylic acid and cardiovascular drugs. Most ADR cases present as gastrointestinal bleeding and adverse cardiovascular effects. Apart from this, one or more drugs are withdrawn from the market each year because of unwanted but mostly rare side effects. In recent years the most prominent cases were rofecoxib, cisapride and cerivastatin. Physicians in Germany are obliged to report ADR. A substantial proportion of ADR, however, is not reported because it is deemed to be either too well known or the association between the drug and the adverse effect is too doubtful. In some cases, histopathological findings are needed to determine the diagnosis of ADR. Accordingly, physicians should inform the pathologist whether an ADR is suspected and which drugs may be responsible.

Entities:  

Mesh:

Year:  2006        PMID: 16341515     DOI: 10.1007/s00292-005-0805-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  28 in total

1.  Accuracy of hepatic adverse drug reaction reporting in one English health region.

Authors:  G P Aithal; M D Rawlins; C P Day
Journal:  BMJ       Date:  1999-12-11

Review 2.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

4.  [Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].

Authors:  T K Hoffmann; S von Schmiedeberg; M Wulferink; R Thier; H Bier; T Ruzicka; P Lehmann
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

5.  Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.

Authors:  Steffen Haffner; Nicoletta von Laue; Stefan Wirth; Petra A Thürmann
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

Review 8.  Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus.

Authors:  D Bjorkman
Journal:  Am J Med       Date:  1998-11-02       Impact factor: 4.965

9.  Systems analysis of adverse drug events. ADE Prevention Study Group.

Authors:  L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

10.  Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998).

Authors:  A Queisser-Luft; G Stolz; A Wiesel; K Schlaefer; J Spranger
Journal:  Arch Gynecol Obstet       Date:  2002-07       Impact factor: 2.344

View more
  4 in total

1.  Biological therapies: concepts and challenges.

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

2.  [Drug-induced pulmonary damage].

Authors:  K-M Müller; B M Einsfelder
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

Review 3.  Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?

Authors:  Subrahmanyam Vangala; Alfred Tonelli
Journal:  AAPS J       Date:  2007-07-20       Impact factor: 4.009

4.  Effects of Allium mongolicum Regel and Its Flavonoids on Constipation.

Authors:  Yue Chen; Zhijuan Ding; Yuzheng Wu; Qian Chen; Mengyang Liu; Haiyang Yu; Dan Wang; Yi Zhang; Tao Wang
Journal:  Biomolecules       Date:  2019-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.